ARTICLE | Company News
Dishman Pharmaceuticals & Chemical, Redx Pharma deal
September 24, 2012 7:00 AM UTC
Redx granted Dishman rights to IP covering its process technology to develop statins. Redx declined to provide details, while Dishman could not be reached. ...